Enteric-Coated Mycophenolate Sodium can be Safely Administered in Maintenance Renal Transplant Patients: Results of a 1-Year Study
Version of Record online: 28 JAN 2004
American Journal of Transplantation
Volume 4, Issue 2, pages 237–243, February 2004
How to Cite
Budde, K., Curtis, J., Knoll, G., Chan, L., Neumayer, H.-H., Seifu, Y., Hall, M. and B302 Study Group (2004), Enteric-Coated Mycophenolate Sodium can be Safely Administered in Maintenance Renal Transplant Patients: Results of a 1-Year Study. American Journal of Transplantation, 4: 237–243. doi: 10.1046/j.1600-6143.2003.00321.x
- Issue online: 28 JAN 2004
- Version of Record online: 28 JAN 2004
- Received 22 May 2003, revised 5 September 2003 and accepted for publication 25 September 2003
- 4A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients . Liver Transpl 2001 ; 7 : 442 – 450 ., , et al.
- 6Efficacy comparison of discharge immunosuppressive regimens in cadaveric kidney transplantation. what is the best combination ? Am J Transplant 2002 ; 2 ( S3 ): 468 [ abstract ]., , , , .
- 10Pharmacokinetic and pharmacodynamic comparison of mycophenolate mofetil and enteric-coated mycophenolate sodium in maintenance transplant patients . Am J Transplant 2002 ; 2 ( S3 ): 399 [ abstract ]., , et al.